Neochem Bio Solutions Limited (NSE:NEOCHEM)
India · Delayed Price · Currency is INR 93.90
-1.35 (-1.42%)
At close: Sep 7, 2026
Neochem Bio Solutions Revenue
In the fiscal year ending March 31, 2026, Neochem Bio Solutions had annual revenue of 1.11B INR with 31.51% growth. Neochem Bio Solutions had revenue of 324.34M in the quarter ending March 31, 2026.
Revenue
1.11B
Revenue Growth
+31.51%
P/S Ratio
1.50
Revenue / Employee
17.03M
Employees
65
Market Cap
1.67B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.11B | 265.27M | 31.51% |
| Mar 31, 2025 | 841.73M | 229.13M | 37.40% |
| Mar 31, 2024 | 612.60M | 130.72M | 27.13% |
| Mar 31, 2023 | 481.88M | -13.83M | -2.79% |
| Mar 31, 2022 | 495.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Mangalam Organics | 6.55B |
| DCM Shriram Fine Chemicals | 3.78B |
| Vikas Ecotech | 3.69B |
| National Peroxide | 3.19B |
| Shree Hari Chemicals Export | 2.15B |
| Archit Organosys | 1.45B |
| Patel Chem Specialities | 1.37B |
| Renol Polychem | 902.29M |